Home › Funds › Point72 Asset Management › ABOS
Point72 Asset Management position in ABOS
ACUMEN PHARMACEUTICALS INC · Health Care
Latest position (Q1 2026)67.38K sh
Reported value held$159.00K
Portfolio Weight0.00%
First reportedQ1 2022
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2022 | 55.05K | $215.00K | New |
| Q3 2022 | 40.94K | $411.00K | New |
| Q1 2023 | 3.95K | $16.05K | New |
| Q4 2025 | 36.37K | $76.73K | New |
| Q1 2026 | 67.38K | $159.00K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ABOS
- BlackRock Inc 2.49M sh · $6.65M · Q2 2026
- Franklin Resources 2.31M sh · $6.15M · Q2 2026
- Vanguard Group 1.65M sh · $3.49M · Q4 2025
- Geode Capital Management 1.14M sh · $3.05M · Q2 2026
- Renaissance Technologies 675.02K sh · $1.80M · Q2 2026
- Two Sigma Investments 622.88K sh · $1.66M · Q2 2026
- Northern Trust Corp 360.74K sh · $963.19K · Q2 2026
- Bank of America Corp 274.78K sh · $733.66K · Q2 2026
- Goldman Sachs Group 183.93K sh · $491.08K · Q2 2026
- Morgan Stanley 136.76K sh · $365.16K · Q2 2026
- BNY Mellon 124.38K sh · $332.09K · Q2 2026
- Charles Schwab Investment Management 115.10K sh · $307.31K · Q2 2026